Lv1
48 积分 2025-12-25 加入
Multiple Sclerosis Disease-Modifying Treatment Algorithms: 2025 Positioning of the Portuguese Multiple Sclerosis Study Group
1个月前
已完结
Avacopan for the Treatment of ANCA-Associated Vasculitis
1个月前
已完结
Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: A systematic review and network meta-analysis
1个月前
已完结
Titin and ryanodine receptor antibodies in myasthenia gravis
1个月前
已完结
Clinical characteristics and outcomes of thymoma‐associated myasthenia gravis
2个月前
已完结
Effectiveness of treatments in Neuromyelitis optica to modify the course of disease in adult patients. Systematic review of literature
2个月前
已完结
Early anti-C5 therapy in NMOSD: rationale and clinical evidence
2个月前
已完结
Blood-Based Biomarkers for Identifying Disease Activity in AQP4-IgG–Positive Neuromyelitis Optica Spectrum Disorder
2个月前
已完结
皖公网安备34019202002308
